• Internal medicine · Aug 2024

    Case Reports

    Remission of Cardiac Sarcoidosis after the Administration of Methotrexate as First-line Drug Therapy.

    • Hirochika Yamasaki, Hidekazu Kondo, Naoko Ogawa, Kazuki Mitarai, Yumi Ishi, Shotaro Saito, and Naohiko Takahashi.
    • Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Japan.
    • Intern. Med. 2024 Aug 1; 63 (15): 214921522149-2152.

    AbstractA 54-year-old woman developed new-onset heart failure and was diagnosed with cardiac sarcoidosis. An implantable cardioverter-defibrillator with biventricular pacing was implanted before immunosuppressive therapy to prevent sudden death. The patient refused oral steroids because she disliked their specific side effects and potential adverse events with long-term use; therefore, methotrexate was chosen as an alternative first-line drug. Nine months after starting oral therapy, 18F-fluorodeoxyglucose-positron emission tomography revealed remission of sarcoidosis, disappearance of heart failure symptoms, marked improvement in cardiac contractility, and a reduced frequency of ventricular arrhythmias.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…